Judith M. Ramage

University Park
Nottingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Single-Cell Transcriptomic Analysis Reveals γδ T-Cell Infiltration and Presence of Immune Regulatory Molecules in Biliary Tract Cancer Microenvironment.

Single-Cell Transcriptomic Analysis Reveals γδ T-Cell Infiltration and Presence of Immune Regulatory Molecules in Biliary Tract Cancer Microenvironment.

Journal: American journal of clinical oncology

Published: May 05, 2026

Epigenetic Regulation of Immune Responses in Endocrine-Related Cancers and Its Role in Immunotherapy.

Epigenetic Regulation of Immune Responses in Endocrine-Related Cancers and Its Role in Immunotherapy.

Journal: Cancers

Published: August 27, 2025

Multi-omic approach identifies hypoxic tumor-associated myeloid cells that drive immunobiology of high-risk pediatric ependymoma.

Multi-omic approach identifies hypoxic tumor-associated myeloid cells that drive immunobiology of high-risk pediatric ependymoma.

Journal: iScience

Published: January 09, 2023

Activated tissue resident memory T-cells (CD8+CD103+CD39+) uniquely predict survival in left sided "immune-hot" colorectal cancers.

Activated tissue resident memory T-cells (CD8+CD103+CD39+) uniquely predict survival in left sided "immune-hot" colorectal cancers.

Journal: Frontiers in immunology

Published: September 29, 2022

Engineering the Human Fc Region Enables Direct Cell Killing by Cancer Glycan-Targeting Antibodies without the Need for Immune Effector Cells or Complement.

Engineering the Human Fc Region Enables Direct Cell Killing by Cancer Glycan-Targeting Antibodies without the Need for Immune Effector Cells or Complement.

Journal: Cancer research

Published: November 21, 2019

Connexin 43 is an independent predictor of patient outcome in breast cancer patients.

Connexin 43 is an independent predictor of patient outcome in breast cancer patients.

Journal: Breast cancer research and treatment

Published: November 05, 2018

High mobility group protein B1 is a predictor of poor survival in ovarian cancer.

High mobility group protein B1 is a predictor of poor survival in ovarian cancer.

Journal: Oncotarget

Published: January 06, 2017

SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade.

SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade.

Journal: Oncoimmunology

Published: November 17, 2015

Stromal fibroblasts support dendritic cells to maintain IL-23/Th17 responses after exposure to ionizing radiation.

Stromal fibroblasts support dendritic cells to maintain IL-23/Th17 responses after exposure to ionizing radiation.

Journal: Journal of leukocyte biology

Published: October 16, 2015

CD55 costimulation induces differentiation of a discrete T regulatory type 1 cell population with a stable phenotype.

CD55 costimulation induces differentiation of a discrete T regulatory type 1 cell population with a stable phenotype.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: November 08, 2013

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.

Journal: British journal of cancer

Published: March 15, 2012

The use of reverse immunology to identify HLA-A2 binding epitopes in Tie-2.

The use of reverse immunology to identify HLA-A2 binding epitopes in Tie-2.

Journal: Cancer immunology, immunotherapy : CII

Published: October 26, 2005

Showing 1-12 of 14

Last Updated: 09/26/2026